Assessment of lymphocyte subsets and neutrophil leukocyte function in chronic psychiatric patients on long-term drug therapy

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 20, Issue 7, 1996, Pages 1117-1129

  Cosentino, Marco ^a   Fietta, Annamaria ^a   Caldiroli, Emanuela ^a   Marino, Franca ^a   Rispoli, Laura ^b   Comelli, Mario ^a   Lecchini, Sergio ^a   Frigo, Gianmario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Psychiatric Unit   (Italy)

Author keywords

benzodiazepines; carbamazepine; lymphocyte subsets; neuroleptics; neutrophil leukocyte function; psychiatric patients

Indexed keywords

BENZODIAZEPINE; BROMAZEPAM; CARBAMAZEPINE; CLOTIAPINE; FLUNITRAZEPAM; FLUPHENAZINE DECANOATE; HALOPERIDOL; HALOPERIDOL DECANOATE; LEVOMEPROMAZINE; LORAZEPAM; NEUROLEPTIC AGENT; PERICIAZINE; PIPAMPERONE; PROMAZINE; SULTOPRIDE; TEMAZEPAM; THIORIDAZINE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOLOGY; LEUKOCYTE; LYMPHOCYTE; NEUTROPHIL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA;

ADULT; AGED; AGED, 80 AND OVER; CD4 LYMPHOCYTE COUNT; CHRONIC DISEASE; FEMALE; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MENTAL DISORDERS; MIDDLE AGED; NEUTROPHILS; PHAGOCYTOSIS; PSYCHOTROPIC DRUGS;

EID: 0030273693     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(96)00100-5     Document Type: Article

References (40)

1. ADER R., COHEN N. and FELTEN D. (1995) Psychoneuroimmunology: Interactions between the nervous system and the immune system. Lancet, 345: 99-103.
2. ADER R. and FELTEN D.L. and COHEN N. (1991) Psychoneuroimmunology, Academic Press Limited, London, pp 953.
3. BASARAN N., HINCAL F., KANSU E. and CIGER A. (1994) Humoral and cellular immune parameters in untreated and phenytoin-or carbamazepine-treated epileptic patients. Int. J. Immunopharmacol., 16: 1071-1077.
4. COFFEY C.E., SULLIVAN J.L. and RICE J.R. (1983) T lymphocytes in schizophrenia. Biol. Psychiatry, 18: 113-119.
5. COHEN H.J., CHOVANIEC M.E. and ELLIS S.E. (1980) Chlorpromazine inhibition of granulocyte superoxide production. Blood, 56: 23-29.
6. COVELLI V., DECANDIA P., ALTAMURA M. and JIRILLO E. (1989) Diazepam inhibits phagocytosis and killing exerted by polymorphonuclear cells and monocytes from healthy donors. In vitro studies. Immunopharmacol. Immunotoxicol., 11: 701-714.
7. COVELLI V., GRASSI P.P., MAFFIONE A.B., CATINO A. and JIRILLO E. (1988) Impairment of non-specific immunity in patients with anxiety disorders (phobic disorders). New Trends in Exp. Clin. Psychiatr., 4: 37-45.
8. COVELLI V., MAFFIONE A.B., GRECO B., CANNUSCIO B., CALVELLO R. and JIRILLO E. (1993) In vivo effects of alprazolam and lorazepam on the immune response in patients with migraine without aura. Immunopharmacol. Immunotoxicol., 15: 415-428.
9. DE LISI L.E. and WYATT R.J. (1982) Abnormal immune regulation in schizophrenic patients. Psychopharmacol. Bull., 18: 158-163.
10. DESCOTES J. (1988) Immunotoxicity of drugs acting on the nervous system. In: Immunotoxicity of drugs and chemicals, J. Descotes (Ed), pp 129-165, Elsevier, Amsterdam New York Oxford.
11. FINNERTY M., MARCZYNSKI T.J., AMIRAULT H.J., URBANCIC M. and ANDERSEN B.R. (1991) Benzodiazepines inhibit neutrophil chemotaxis and superoxide production in a stimulus dependent manner; PK-11195 antagonizes these effects. Immunopharmacology, 22: 185-194.
12. GANGULI R., RABIN B.S., KELLY R.H., LYTE M. and RAGU U. (1987) Clinical and laboratory evidence of autoimmunity in acute schizophrenia. Ann. N. Y. Acad. Sci., 496: 676-685.
13. GILHUS N.E. and MATRE R. (1986) Carbamazepine effects on mononuclear blood cells in epileptic patients. Acta Neurol. Scand., 74: 181-185.
14. GOLDFARB G., BELGHITI J., GAUTERO H. and BOIVIN P. (1984) In vitro effect of benzodiazepines on polymorphonuclear leukocyte oxidative activity. Anesthesiology, 60: 57-60.
15. HIRATA-HIBI M., HIGASHI S., TACHIBANA T. and WATANABE N. (1982) Stimulated lymphocytes in schizophrenia. Arch. Gen. Psychiatry, 39: 82-87.
16. KEUSCH G.T., DOUGLAS S.D. and UGURBIL K. (1975) Intracellular bactericidal activity of leukocytes in whole blood for the diagnosis of chronic granulomatous disease of childhood. J. Infect. Dis., 131: 584-587.
17. LAGHI PASINI F., CECCATELLI L., CAPECCHI P.L., ORRICO A., PASQUI A.L. and DI PERRI T. (1987) Benzodiazepines inhibit in vitro free radical formation from human neutrophils induced by FMLP and A23187. Immunopharmacol. Immunotoxicol., 9: 101-114.
18. LASCHI A., DESCOTES J., TACHON P. and EVREUX J.C. (1983) Adverse influence of diazepam upon resistance to Klebsiella pneumoniae infection in mice. Toxicol. Lett., 16: 281-284.
19. LECHIN F., VAN DER DIJS B., VITELLI-FLORES G., BAEZ S., LECHIN M.E., LECHIN A.E., OROZCO B., RADA I., LEON G. and JIMENEZ V. (1994) Peripheral blood immunological parameters in long-term benzodiazepine users. Clin. Neuropharmacol., 17: 63-72.
20. LEHRER R.I. and CLINE M.J. (1969) Leukocyte myeloperoxidase deficiency and disseminated candidiasis: The role of myeloperoxidase in resistance to Candida infection. J. Clin. Invest., 48: 1478-1488.
21. LIEDEMAN R.R. and PRILIPKO L.L. (1978) The behavior of T lymphocytes in schizophrenia. In: Neurochemical and immunological components in schizophrenia. (Original article series: Birth Defects), Vol 18, D. Bergsma and A.L. Goldstein (Eds.), pp 365-377, Alan R., Liss Co., New York.
22. LIVEZEY G.T., MARCZYNSKI T.J., MCGREW E.A. and BELUHAN F.Z. (1986) Prenatal exposure to diazepam: late postnatal teratogenic effect. Neurobehav. Toxicol. Teratol., 8: 433-440.
23. MARCOLI M., GATTI G., IPPOLITI G., LOMBARDI M., CREMA A., ZOCCHI M.T., DE PONTI F., LECCHINI S. and FRIGO G.M. (1985) Effect of chronic anticonvulsant monotherapy on lymphocyte subpopulations in adult epileptic patients. Hum. Toxicol., 4: 147-157.
24. MC ADAMS C. and LEONARD B.E. (1993) Neutrophil and monocyte phagocytosis in depressed patients. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 17: 971-984.
25. MONTELEONE P., VALENTE B., MAJ M. and KEMALI D. (1991) Reduced lymphocyte response to PHA and OKT3 in drug-free and neuroleptic-treated chronic schizophrenics. Biol. Psychiatry, 30: 201-204.
26. MOON B.C., GIROTTI M.J., WREN S.F.G., DAWSON R. and BRAR D. (1986) Effect of antibiotics and sedatives on normal neutrophil nicotinamide-adenine dinucleotide phosphate-reduced oxidase activity. Arch. Surg., 121: 73-76.
27. MÜLLER N., ACKENHEIL M., HOFSCHUSTER E., MEMPEL W. and ECKSTEIN R. (1991) Cellular immunity in schizophrenic patients before and during neuroleptic treatment. Psychiatry Res., 37: 147-160.
28. NYLAND H., NESS A. and LUNDE H. (1980) Lymphocyte subpopulations in peripheral blood from schizophrenic patients. Acta psychiatr. Scand., 61: 313-318.
29. O'NEILL B. and LEONARD B.E. (1986) Is there an abnormality in neutrophil phagocytosis in depression? IRCS Med. Sci., 14: 802-803.
30. O'NEILL B. and LEONARD B.E. (1990) Abnormal zymosan-induced neutrophil chemiluminescence as a marker of depression. J. Affective Disord., 19: 265-272.
31. OCHS D.L. and REED P.W. (1981) Inhibition of the neutrophil oxidative burst and degranulation by phenothiazines. Biochem. Biophys. Res. Commun., 102: 958-962.
32. PACIFICI R., PARIS L., DI CARLO S., PICHINI S. and ZUCCARO P. (1991) Immunologic aspects of carbamazepine treatment in epileptic patients. Epilepsia, 32: 122-127.
33. PREISIG E. and HITZIG W.H. (1971) Nitroblue-tetrazolium test for the detection of chronic granulomatous disease - Technical modification. Eur. J. Clin. Invest., 1: 409-412.
34. RICEVUTI G., MARCOLI M., GATTI G., MAZZONE A., LECCHINI S. and FRIGO G.M. (1986) Assessment of polymorphonucleate leukocyte functions in adult epileptic patients undergoing long-term phenytoin treatment. Hum. Toxicol., 5: 237-241.
35. SASAKI T., NANKO S., FUKUDA R., KAWATE T., KUNUGI H. and KAZAMATSURI H. (1994) Changes of immunological functions after acute exacerbation in schizophrenia. Biol. Psychiatry, 35: 173-178.
36. SMITH R.J., BOWMAN B.J. and IDEN S.S. (1981) Effects of trifluoperazine on human neutrophil function. Immunology, 44: 677-684.
37. TANIGUCHI K., URAKAMI M. and TAKANAKA K. (1988) Effects of various drugs on superoxide generation, arachidonic acid release and phospholipase A2 in polymorphonuclear leukocytes. Jpn. J. Pharmacol., 46: 275-284.
38. WILKINSON P.C. (1977) Neutrophil leukocyte function test. Techniques In: Clinical Immunology, R.A. Thompson (Ed), pp 201-204, Blackwell Scientific Publication, Oxford.
39. WORLD HEALTH ORGANISATION. (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines (CDDG). WHO Geneva.
40. ZIGMOND S.H. and HIRSCH J.G. (1973) Leukocyte locomotion and chemotaxis: new methods for evaluation, and demonstration of a cell-derived chemotactic factor. J. Exp. Med., 137: 387-410.